SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC
Brian M. Shuch, MD Yale School of Medicine, discusses the SWOG S1500 - Randomized Phase II Trial Efficacy assessment of multiple MET kinase inhibitors in metastatic PRCC at Kidney Cancer Association 2...
Author: kidneycancer
Added: 04/03/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts